Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.5177
-0.0150-2.82%
Pre-market: 0.52390.0062+1.20%05:19 EDT
Volume:5.75M
Turnover:3.01M
Market Cap:143.92M
PE:-1.04
High:0.5480
Open:0.5400
Low:0.5104
Close:0.5327
52wk High:2.55
52wk Low:0.5104
Shares:278.00M
Float Shares:245.00M
Volume Ratio:1.65
T/O Rate:2.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:4.60
PE(LYR):-2.01

Loading ...

Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Qiagen (QGEN)

TIPRANKS
·
Jun 17

U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower

Reuters
·
Jun 17

Humacyte Inc : TD Cowen Cuts Target Price to $1.25 From $1.5

THOMSON REUTERS
·
Jun 17

Humacyte Price Target Maintained With a $2.00/Share by BTIG

Dow Jones
·
Jun 16

Humacyte says Phase 3 study shows bioengineered ATEV blood vessel beats AV fistula in women on dialysis

Reuters
·
Jun 15

Humacyte - Enters Underwriting Agreement for Underwritten Offering on June 10, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 12

Humacyte Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 11

Humacyte, Inc. : H.c. Wainwright Raises Target Price to $4 From $3

THOMSON REUTERS
·
Jun 11

BUZZ-U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte

Reuters
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Humacyte prices 47,619,048-share follow-on offering at $1.05 each to raise $50 million

Reuters
·
Jun 11

Humacyte - Prices Public Offering of 47.62 Mln Shares at $1.05 per Share

THOMSON REUTERS
·
Jun 11

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

GlobeNewswire
·
Jun 11

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

Dow Jones
·
Jun 11

Humacyte's Bioengineered Blood Vessel Hits Primary Endpoint in Phase 3 Trial

Dow Jones
·
Jun 11

Humacyte Says ATEV Met Late-Stage Study Endpoint in Interim Analysis, Launches Public Offering; Shares Fall

MT Newswires Live
·
Jun 11

BRIEF-Humacyte, Inc. Announces Proposed Public Offering Of Common Stock

Reuters
·
Jun 11

Humacyte announces V012 study of ATEV meets primary endpoint

TIPRANKS
·
Jun 11

Humacyte announces common stock offering, no amount given

TIPRANKS
·
Jun 11

Humacyte launches underwritten follow-on common stock offering

Reuters
·
Jun 11